Iambic Therapeutics, Inc. - (IAM) share price
Iambic Therapeutics, Inc. - (NASDAQ:IAM) last traded at $10.17, down 12.63% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.48B and a 52-week range of $9.6 to $25.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $10.17 |
| 1-day move | -12.63% |
| 52-week range | $9.6 - $25 |
| Market cap | $0.48B |
| From 52-week high | -59.30% |
| Volume vs average | 0.8x |
| Falling Shares risk score | 75/100 (CRITICAL) |
| Country | United States |
Frequently asked questions
Why is Iambic Therapeutics, Inc. - falling today?
Iambic Therapeutics, Inc. - (NASDAQ:IAM) is down 12.63% at its latest quote and trades 59.3% below its 52-week high, at a new 52-week low. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Iambic Therapeutics, Inc. - share price today?
Iambic Therapeutics, Inc. - (NASDAQ:IAM) last traded at $10.17, a -12.63% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Iambic Therapeutics, Inc. -?
Iambic Therapeutics, Inc. -'s 52-week low is $9.6 and its 52-week high is $25; the shares trade 59.3% below the high.
What is the market cap of Iambic Therapeutics, Inc. -?
Iambic Therapeutics, Inc. - has a market capitalisation of about $0.48B at the latest price.
What are the risks of investing in Iambic Therapeutics, Inc. -?
Falling Shares Intelligence rates Iambic Therapeutics, Inc. - 75/100 (CRITICAL) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com